Cargando…

The evolving treatment paradigm of lung cancer in China

Detalles Bibliográficos
Autores principales: Xie, Wei, Liu, Shuanghuan, Li, Guanqiao, Xu, Huiyan, Zhou, Liyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069462/
https://www.ncbi.nlm.nih.gov/pubmed/35530151
http://dx.doi.org/10.1016/j.apsb.2022.01.010
_version_ 1784700436022820864
author Xie, Wei
Liu, Shuanghuan
Li, Guanqiao
Xu, Huiyan
Zhou, Liyun
author_facet Xie, Wei
Liu, Shuanghuan
Li, Guanqiao
Xu, Huiyan
Zhou, Liyun
author_sort Xie, Wei
collection PubMed
description
format Online
Article
Text
id pubmed-9069462
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90694622022-05-05 The evolving treatment paradigm of lung cancer in China Xie, Wei Liu, Shuanghuan Li, Guanqiao Xu, Huiyan Zhou, Liyun Acta Pharm Sin B News Elsevier 2022-03 2022-01-29 /pmc/articles/PMC9069462/ /pubmed/35530151 http://dx.doi.org/10.1016/j.apsb.2022.01.010 Text en © 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle News
Xie, Wei
Liu, Shuanghuan
Li, Guanqiao
Xu, Huiyan
Zhou, Liyun
The evolving treatment paradigm of lung cancer in China
title The evolving treatment paradigm of lung cancer in China
title_full The evolving treatment paradigm of lung cancer in China
title_fullStr The evolving treatment paradigm of lung cancer in China
title_full_unstemmed The evolving treatment paradigm of lung cancer in China
title_short The evolving treatment paradigm of lung cancer in China
title_sort evolving treatment paradigm of lung cancer in china
topic News
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069462/
https://www.ncbi.nlm.nih.gov/pubmed/35530151
http://dx.doi.org/10.1016/j.apsb.2022.01.010
work_keys_str_mv AT xiewei theevolvingtreatmentparadigmoflungcancerinchina
AT liushuanghuan theevolvingtreatmentparadigmoflungcancerinchina
AT liguanqiao theevolvingtreatmentparadigmoflungcancerinchina
AT xuhuiyan theevolvingtreatmentparadigmoflungcancerinchina
AT zhouliyun theevolvingtreatmentparadigmoflungcancerinchina
AT xiewei evolvingtreatmentparadigmoflungcancerinchina
AT liushuanghuan evolvingtreatmentparadigmoflungcancerinchina
AT liguanqiao evolvingtreatmentparadigmoflungcancerinchina
AT xuhuiyan evolvingtreatmentparadigmoflungcancerinchina
AT zhouliyun evolvingtreatmentparadigmoflungcancerinchina